The Value of Combining Serum Alanine Aminotransferase Levels and Body Mass Index to Predict Mortality and Medical Costs: a 10-year Follow-up Study of National Health Insurance in Shiga, Japan

BACKGROUND Evidence suggests that the predictive value of serum alanine aminotransferase (ALT) levels for prognosis, measured by indices such as all-cause mortality and medical costs, may be modified by body mass index (BMI). However, the relationship between serum ALT and BMI has not been satisfactorily elucidated. METHODS Four thousand, five hundred and twenty-four community dwelling Japanese National Health Insurance beneficiaries, 40-69 years old, were classified into five categories according to their serum ALT levels (IU/L) (ALT<20, 20≤ALT<30, 30≤ALT<40, 40≤ALT<50 and 50≤ALT) and followed for 10 years. Hazard ratios for all-cause mortality, with reference to the lowest serum ALT category, and medical costs per person were evaluated for each serum ALT category after analyzing interactions between serum ALT levels and BMI for all-cause mortality and for medical costs. RESULTS A significant interaction between serum ALT levels and BMI was observed. In participants below the median BMI, positive, graded relationships were identified between serum ALT levels and all-cause mortality as well as between serum ALT levels and personal medical costs. The multivariate-adjusted hazard ratio in the “50≤ALT” category showed an approximately 8-fold increase. However, in the participants at or above the median BMI, no significant relationships between serum ALT levels and all-cause mortality or personal medical costs were identified. CONCLUSIONS In these Japanese participants, the predictive value of serum ALT levels for prognosis was more evident if BMI was taken into account. A combination of high serum ALT levels and below median BMI was associated with excess mortality and medical costs.

[1]  A. Oshima,et al.  Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus‐positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus , 2004, International journal of cancer.

[2]  Akihiro Matsumoto,et al.  Hepatocellular carcinoma: recent trends in Japan. , 2004, Gastroenterology.

[3]  Jane B Shofer,et al.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.

[4]  P. Elliott,et al.  Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. , 2004, American heart journal.

[5]  K. Shimamoto.  [Epidemiologic study on metabolic syndrome--comparison between Japan and western countries]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[6]  P Christoffersen,et al.  Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.

[7]  E. Ford.  The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. , 2004, Atherosclerosis.

[8]  I. Suh,et al.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study , 2004, BMJ : British Medical Journal.

[9]  P. Elliott,et al.  Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: The INTERMAP Study , 2003, Journal of Human Hypertension.

[10]  C. Alessandri,et al.  Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases , 2003, Journal of gastroenterology and hepatology.

[11]  H. Ueshima,et al.  What cause of mortality can we predict by cholesterol screening in the Japanese general population? , 2003, Journal of internal medicine.

[12]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[13]  L. Caregaro,et al.  Nutrition and survival in patients with liver cirrhosis. , 2001, Nutrition.

[14]  Chien-Jen Chen,et al.  Epidemiology of hepatitis B virus infection in the Asia–Pacific region , 2000, Journal of gastroenterology and hepatology.

[15]  M. Kaplan,et al.  Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.

[16]  H. Ueshima,et al.  Stroke incidence and case fatality in Shiga, Japan 1989-1993. , 1999, International journal of epidemiology.

[17]  H. Brenner,et al.  Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality , 1998, International archives of occupational and environmental health.

[18]  T. Nakayama,et al.  A brief review of epidemiological studies on ischemic heart disease in Japan. , 1996, Journal of epidemiology.

[19]  S. Kashiwagi,et al.  Hepatitis C virus is a more likely cause of chronic liver disease in the Japanese population than hepatitis B virus. , 1991, Fukuoka igaku zasshi = Hukuoka acta medica.

[20]  Y Hattori,et al.  [A study on fatty liver in health examination participants]. , 1989, Nihon eiseigaku zasshi. Japanese journal of hygiene.

[21]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[22]  H. Ueshima.  Changes in dietary habits, cardiovascular risk factors and mortality in Japan. , 1990, Acta cardiologica.

[23]  H. Ueshima,et al.  Declining mortality from ischemic heart disease and changes in coronary risk factors in Japan, 1956-1980. , 1987, American journal of epidemiology.